| Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses A Antonelli, SM Ferrari, F Ragusa, G Elia, SR Paparo, I Ruffilli, A Patrizio, ... Best practice & research Clinical endocrinology & metabolism 34 (1), 101387, 2020 | 206 | 2020 |
| Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer A Cristaudo, R Foddis, A Vivaldi, G Guglielmi, N Dipalma, R Filiberti, ... Clinical Cancer Research 13 (17), 5076-5081, 2007 | 180 | 2007 |
| SV40 infection induces telomerase activity in human mesothelial cells R Foddis, A De Rienzo, D Broccoli, M Bocchetta, E Stekala, P Rizzo, ... Oncogene 21 (9), 1434-1442, 2002 | 138 | 2002 |
| Mental health of Health Care Workers (HCWs): a review of organizational interventions put in place by local institutions to cope with new psychosocial challenges resulting from … R Buselli, M Corsi, A Veltri, S Baldanzi, M Chiumiento, E Del Lupo, ... Psychiatry research 299, 113847, 2021 | 129 | 2021 |
| SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study A Cristaudo, R Foddis, A Vivaldi, R Buselli, V Gattini, G Guglielmi, ... Cancer research 65 (8), 3049-3052, 2005 | 113 | 2005 |
| SV40 and the pathogenesis of mesothelioma P Rizzo, M Bocchetta, A Powers, R Foddis, E Stekala, HI Pass, ... Seminars in cancer biology 11 (1), 63-71, 2001 | 93 | 2001 |
| Expression status of candidate genes in mesothelioma tissues and cell lines O Melaiu, E Melissari, L Mutti, E Bracci, C De Santi, C Iofrida, M Di Russo, ... Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 771, 6-12, 2015 | 85 | 2015 |
| A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma O Melaiu, A Cristaudo, E Melissari, M Di Russo, A Bonotti, R Bruno, ... Mutation Research/Reviews in Mutation Research 750 (2), 132-140, 2012 | 68 | 2012 |
| Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma A Cristaudo, A Bonotti, S Simonini, A Vivaldi, G Guglielmi, N Ambrosino, ... Journal of thoracic oncology 6 (9), 1587-1593, 2011 | 67 | 2011 |
| Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma A Cristaudo, R Foddis, A Bonotti, S Simonini, A Vivaldi, G Guglielmi, ... The International journal of biological markers 25 (3), 164-170, 2010 | 55 | 2010 |
| Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism C De Santi, O Melaiu, A Bonotti, L Cascione, G Di Leva, R Foddis, ... Scientific reports 7 (1), 3140, 2017 | 54 | 2017 |
| Evaluation of flu vaccination coverage among healthcare workers during a 3 years’ study period and attitude towards influenza and potential COVID-19 vaccination in the context … G Scardina, L Ceccarelli, V Casigliani, S Mazzilli, M Napoletano, ... Vaccines 9 (7), 769, 2021 | 38 | 2021 |
| MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma O Melaiu, J Stebbing, Y Lombardo, E Bracci, N Uehara, A Bonotti, ... PLoS One 9 (1), e85935, 2014 | 38 | 2014 |
| Serum mesothelin and other biomarkers: what have we learned in the last decade? A Cristaudo, A Bonotti, G Guglielmi, P Fallahi, R Foddis Journal of Thoracic Disease 10 (Suppl 2), S353, 2018 | 35 | 2018 |
| Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma A Bonotti, S Simonini, E Pantani, L Giusti, E Donadio, MR Mazzoni, ... The International journal of biological markers 32 (1), 126-131, 2017 | 31 | 2017 |
| A novel panel of serum biomarkers for MPM diagnosis A Bonotti, R Foddis, S Landi, O Melaiu, C De Santi, L Giusti, E Donadio, ... Disease markers 2017 (1), 3510984, 2017 | 28 | 2017 |
| Soluble markers for diagnosis of malignant pleural mesothelioma A Cristaudo, A Bonotti, S Simonini, R Bruno, R Foddis Biomarkers in Medicine 5 (2), 261-273, 2011 | 26 | 2011 |
| Comparative proteomic analysis of malignant pleural mesothelioma evidences an altered expression of nuclear lamin and filament‐related proteins L Giusti, Y Da Valle, A Bonotti, E Donadio, F Ciregia, T Ventroni, R Foddis, ... PROTEOMICS–Clinical Applications 8 (3-4), 258-268, 2014 | 24 | 2014 |
| Putative biomarkers for malignant pleural mesothelioma suggested by proteomic analysis of cell secretome S Lacerenza, F Ciregia, L Giusti, A Bonotti, V Greco, G Giannaccini, ... Cancer genomics & proteomics 17 (3), 225-236, 2020 | 23 | 2020 |
| Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein A Cristaudo, R Foddis, A Bonotti, S Simonini, A Vivaldi, G Guglielmi, ... Occupational and environmental medicine 67 (4), 233-236, 2010 | 22 | 2010 |
